FDA Drug recall D-829-2013
Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only
- FDA Drug
- Class II
- terminated
- Published 2013-08-07
On 2013-08-07 the FDA classified a Class II recall of Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only by Actavis South Atlantic, citing failed Impurity/Degradation Specification; "Related Compound C".
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-829-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-05-15 |
| Published | 2013-08-07 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Actavis South Atlantic |
| Distribution | US |
Product
Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only. Manufactured by VistaPharm, Inc., Birmingham, AL 35242. Distributed by Actavis Mid Atlantic LLC 1877 Kawai Road, Lincolnton, NC 28092 USA
Reason
Failed Impurity/Degradation Specification; "Related Compound C"
Identifiers
| code_info | Lot Numbers: 247900, 251000, 256000, 261200, 263600, 266700, 277100, 280300 and 284300. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-829-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.